| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.272.26.16231 |
| P698 | PubMed publication ID | 9195924 |
| P2093 | author name string | M Liu | |
| K Wang | |||
| P V Subbaiah | |||
| J Goyal | |||
| P2860 | cites work | Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase | Q24562119 |
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad | Q28505897 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. | Q33925421 | ||
| Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein | Q34202226 | ||
| Anti-inflammatory properties of a platelet-activating factor acetylhydrolase | Q34307399 | ||
| The role of lipid peroxidation and antioxidants in oxidative modification of LDL. | Q35379559 | ||
| Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase | Q35548859 | ||
| Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells | Q35553734 | ||
| Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children | Q35594599 | ||
| Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells | Q35766281 | ||
| Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein | Q35768830 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes | Q35848282 | ||
| Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids | Q36263522 | ||
| Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins | Q37296651 | ||
| Effects of site-directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity | Q37414301 | ||
| LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture | Q40243249 | ||
| Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor | Q40336954 | ||
| HDL, its enzymes and its potential to influence lipid peroxidation. | Q40475176 | ||
| Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase | Q40949634 | ||
| Mammalian platelet-activating factor acetylhydrolases | Q41005174 | ||
| Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis | Q41335890 | ||
| Roles of cysteines in human lecithin:cholesterol acyltransferase | Q41565116 | ||
| High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein | Q41733901 | ||
| Gas-phase cigarette smoke inhibits plasma lecithin-cholesterol acyltransferase activity by modification of the enzyme's free thiols | Q46065463 | ||
| Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. | Q46132358 | ||
| Chicken lecithin-cholesterol acyltransferase. Molecular characterization reveals unusual structure and expression pattern | Q48069326 | ||
| Formation of platelet-activating factor-like phospholipids by Fe2+/ascorbate/EDTA-induced lipid peroxidation | Q48330817 | ||
| Copper-induced LDL peroxidation investigated by 1H-NMR spectroscopy | Q57925460 | ||
| Release of platelet-activating factor in systemic lupus erythematosus | Q58831832 | ||
| Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated | Q59394776 | ||
| Release of fatty acids from phosphatidylcholine by lecithin-cholesterol acyltransferase. | Q64949995 | ||
| Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters | Q67550112 | ||
| 'A'-esterases. Enzymes looking for a role? | Q69947150 | ||
| Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor | Q70462627 | ||
| Studies on phospholipase A inhibitor in blood plasma. I. Purification and characterization of phospholipase A inhibitor in bovine plasma | Q70675772 | ||
| Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E | Q70742578 | ||
| Vertebrate class distribution of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine acetylhydrolase in serum | Q71012170 | ||
| Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids | Q71127852 | ||
| Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids | Q71913601 | ||
| PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation | Q72282272 | ||
| Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C | Q72314416 | ||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 16231-16239 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation | |
| P478 | volume | 272 |
| Q37351663 | A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration |
| Q36330024 | Aldose reductase-catalyzed reduction of aldehyde phospholipids |
| Q36625116 | Alterations in lipoprotein defense against oxidative stress in metabolic syndrome |
| Q35298513 | Anti-inflammatory properties of lipid oxidation products |
| Q34440172 | Anti-oxidant properties of high-density lipoprotein and atherosclerosis |
| Q41115717 | Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit |
| Q44973369 | Cloning and functional characterization of a phospholipid:diacylglycerol acyltransferase from Arabidopsis |
| Q42993679 | Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids |
| Q38293462 | Dysfunctional HDL: from structure-function-relationships to biomarkers |
| Q73656647 | Electrospray ionization mass spectrometry of lysoglycerophosphocholine lipid subclasses |
| Q38293442 | Functionality of HDL: antioxidation and detoxifying effects |
| Q28389691 | Generation and biological activities of oxidized phospholipids |
| Q43806113 | Genetic differences in hepatic lipid peroxidation potential and iron levels in mice |
| Q77933523 | Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide |
| Q36150462 | High Density Lipoprotein and it's Dysfunction |
| Q37305341 | High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease |
| Q35387923 | Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function |
| Q54029640 | Importance of the free sulfhydryl groups of lecithin-cholesterol acyltransferase for its sensitivity to oxidative inactivation. |
| Q73200588 | Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol |
| Q35007983 | Introduction. Lipid oxidation products and atherosclerosis |
| Q36998113 | Lecithin: cholesterol acyltransferase and na(+)-k(+)-ATPase activity in patients with breast cancer |
| Q36145188 | Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? |
| Q36723319 | Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations |
| Q73901926 | Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease |
| Q53508926 | Multiplatform metabolomic fingerprinting as a tool for understanding hypercholesterolemia in Wistar rats. |
| Q42931336 | Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein |
| Q35936632 | Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans |
| Q77601534 | Oxidized phospholipids as a new landmark in atherosclerosis |
| Q47630637 | Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development |
| Q73350111 | Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis |
| Q28343585 | Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein |
| Q40294302 | Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid |
| Q51735011 | Preferential hydrolysis of truncated oxidized glycerophospholipids by lysosomal phospholipase A2. |
| Q74620349 | Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide |
| Q33588372 | Regulation of lecithin cholesterol acyltransferase activity |
| Q77968336 | Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma |
| Q24294828 | Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase |
| Q39153624 | Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein |
| Q57176950 | Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within |
Search more.